A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 59, Issue 4, Pages 813-820
Publisher
Informa UK Limited
Online
2017-07-18
DOI
10.1080/10428194.2017.1349907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients
- (2016) Fabio Guolo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Acute Myeloid Leukemia: Past, Present, and Prospects for the Future
- (2016) Nicholas J. Short et al. Clinical Lymphoma Myeloma & Leukemia
- How I treat refractory and early relapsed acute myeloid leukemia
- (2015) F. Thol et al. BLOOD
- A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age
- (2015) Sarah A. Buckley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia
- (2015) Tapan M. Kadia et al. CANCER
- Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
- (2015) Farhad Ravandi et al. LANCET ONCOLOGY
- Improving outcomes for patients with acute myeloid leukemia in first relapse: A single center experience
- (2014) Naveen Pemmaraju et al. AMERICAN JOURNAL OF HEMATOLOGY
- International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- (2014) Gail J. Roboz et al. JOURNAL OF CLINICAL ONCOLOGY
- Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
- (2013) Aziz Nazha et al. AMERICAN JOURNAL OF HEMATOLOGY
- Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
- (2013) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
- (2012) Elias Jabbour et al. Clinical Lymphoma Myeloma & Leukemia
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
- (2012) Stefan Faderl et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of clofarabine in acute myeloid leukemia
- (2012) Hady Ghanem et al. LEUKEMIA & LYMPHOMA
- Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
- (2010) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens
- (2010) Samantha L. Price et al. LEUKEMIA RESEARCH
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
- (2009) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search